Cbl-b-IN-5 structure
|
Common Name | Cbl-b-IN-5 | ||
|---|---|---|---|---|
| CAS Number | 2368835-59-8 | Molecular Weight | 339.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H17N5OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Cbl-b-IN-5Cbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 µM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation[1]. |
| Name | Cbl-b-IN-5 |
|---|
| Description | Cbl-b-IN-5 (compound 6) is a Cbl-b inhibitor (IC50=3-10 µM). Cbl-b-IN-5 has the potential to be used in the study of cancer and related diseases amenable to immune system modulation[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: Cbl-b (3-10 µM)[1]. |
| References |
[1]. Paul A. Barsanti, et al. Inhibitors of cbl-b and methods of use thereof. Patent WO2019148005A1. |
| Molecular Formula | C17H17N5OS |
|---|---|
| Molecular Weight | 339.41 |
| InChIKey | BOVJKQTZTZBOBN-UHFFFAOYSA-N |
| SMILES | CC(Sc1nncn1C)c1cccc(NC(=O)c2ccccn2)c1 |